Jason Wild, a Director and 10% Holder, acquired 120,000 Common Shares on a control or direction basis for registered holder JW Growth Fund, LLC 260,000 Common Shares on a control or direction basis for registered holder JW Opportunities Master Fund, Ltd., 620,000 Common Shares on a control or direction basis for registered holder JW Partners, LP and 3,883,745 Common Shares on a control or direction basis for registered holder Pharmaceutical Opportunities Fund, LP at a price of $2.450 through a prospectus or prospectus exempt offering on December 30th, 2019.
The insider also acquired 120,000 Warrants on a control or direction basis for registered holder JW Growth Fund, LLC, 260,000 Warrants on a control or direction basis for registered holder JW Opportunities Master Fund, Ltd., 620,000 Warrants on a control or direction basis for registered holder JW Partners, LP and 3,883,745 Warrants on a control or direction basis for registered holder Pharmaceutical Opportunities Fund, LP with an exercise price of $3.250 prior to January 14, 2022. This represents a $11,965,175 investment into the company's shares and an account share holdings change of greater than 100%.
TerrAscend is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
TerrAscend Corp is a Canada-based company engaged in providing products, brands, and services to the cannabinoid market. The Company, through its subsidiary TerrAscend Canada Inc., is a producer of medical and adult use cannabis. It also operates through various businesses, including The Apothecarium, a cannabis dispensary with retail locations in California and Nevada; Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products; Ascendant Laboratories Inc., a biotechnology and licensing company focused on cannabinoid expressing plants; Solace RX Inc., a Drug Preparation Premises (DPP) focused on the development of formulations and delivery forms; and Valhalla Confections, a manufacturer of premium cannabis-infused edibles.
No Comments